Behavior of neural stem cells in the Alzheimer brain

Cellular and Molecular Life Sciences

Volumn 65, Issue 15, 2008, Pages 2372-2384

  Waldau, B ^a   Shetty, A K ^a  

^a NONE

Author keywords

Alzheimer's disease; Alzheimer's pathology; Dentate neurogenesis; Neural progenitor; Neural stem cell; Stem cell differentiation; Stem cell graft; Stem cell renewal

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; HELIX LOOP HELIX PROTEIN; NEUROTROPHIC FACTOR;

ALZHEIMER DISEASE; AUTOPSY; CELL DIFFERENTIATION; CELL LOSS; CELL PROLIFERATION; DEMENTIA; DENTATE GYRUS; DOWN SYNDROME; GENE; GRANULE CELL; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; MOOD; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW; SELADIN 1 GENE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL DIFFERENTIATION; HUMANS; NEURONS; STEM CELLS;

EID: 49249116020     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8053-y     Document Type: Review

References (111)

1. Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P. R., Rimmer, E. and Scazufca, M. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117.
2. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A. and Evans, D. A. (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60, 1119-1122.
3. Mohs, R. C., Schmeidler, J. and Aryan, M. (2000) Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease. Stat. Med. 19, 1401-1409.
4. Gage, F. H. (2000) Mammalian neural stem cells. Science 287, 1433-1438.
5. Reynolds, B. A. and Weiss, S. (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710.
6. Abrous, D. N., Koehl, M. and Le Moal, M. (2005) Adult neurogenesis: from precursors to network and physiology. Physiol. Rev. 85, 523-569.
7. Gould, E. (2007) How widespread is adult neurogenesis in mammals? Nat Rev Neurosci. 8, 481-488.
8. van Praag, H., Christie, B. R., Sejnowski, T. J. and Gage, F. H. (1999) Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl. Acad. Sci. USA 96, 13427-13431.
9. van Praag, H., Shubert, T., Zhao, C. and Gage, F. H. (2005) Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci. 25, 8680-8685.
10. Kempermann, G., Kuhn, H. G. and Gage, F. H. (1998) Experience-induced neurogenesis in the senescent dentate gyrus. J. Neurosci. 18, 3206-3212.
11. Parent, J. M., Yu, T. W., Leibowitz, R. T., Geschwind, D. H., Sloviter, R. S. and Lowenstein, D. H. (1997) Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci. 17, 3727-3738.
12. Jin, K., Minami, M., Lan, J. Q., Mao, X. O., Batteur, S., Simon, R. P. and Greenberg, D. A. (2001) Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci. USA 98, 4710-4715.
13. Hattiangady, B. and Shetty, A. K. (2008) Aging does not alter the number or phenotype of putative stem/progenitor cells in the neurogenic region of the hippocampus. Neurobiol. Aging 29, 129-147.
14. Hagg, T. (2007) Endogenous regulators of adult CNS neurogenesis. Curr. Pharm. Des. 13, 1829-1840.
15. Gould, E. and Tanapat, P. (1999) Stress and hippocampal neurogenesis. Biol. Psychiatry 46, 1472-1479.
16. Kuhn, H. G., Dickinson-Anson, H. and Gage, F. H. (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16, 2027-2033.
17. Nacher, J., Alonso-Llosa, G., Rosell, D. R. and McEwen, B. S. (2003) NMDA receptor antagonist treatment increases the production of new neurons in the aged rat hippocampus. Neurobiol. Aging 24, 273-284.
18. Rao, M. S., Hattiangady, B., Abdel-Rahman, A., Stanley, D. P. and Shetty, A. K. (2005) Newly born cells in the ageing dentate gyrus display normal migration, survival and neuronal fate choice but endure retarded early maturation. Eur. J. Neurosci. 21, 464-476.
19. Rao, M. S., Hattiangady, B. and Shetty, A. K. (2006) The window and mechanisms of major age-related decline in the production of new neurons within the dentate gyrus of the hippocampus. Aging Cell 5, 545-558.
20. Hattiangady, B., Rao, M. S. and Shetty, A. K. (2004) Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus. Neurobiol. Dis. 17, 473-490.
21. Gould, E., Beylin, A., Tanapat, P., Reeves, A. and Shors, T. J. (1999) Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 2, 260-265.
22. Aimone, J. B., Wiles, J. and Gage, F. H. (2006) Potential role for adult neurogenesis in the encoding of time in new memories. Nat. Neurosci. 9, 723-727.
23. Leuner, B., Gould, E. and Shors, T. J. (2006) Is there a link between adult neurogenesis and learning? Hippocampus 16, 216-224.
24. Sahay, A. and Hen, R. (2007) Adult hippocampal neurogenesis in depression. Nat Neurosci. 10, 1110-1115.
25. Alzheimer, A. (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatrie Psychisch-Gerichtl. Med. 64, 146-148.
26. Alzheimer, A. (1911) Ueber eigenartige Krankheitsfaelle des spaeteren Alters. Zbl. Ges. Neurol. Psych. 4, 356-385.
27. Glenner, G. G. and Wong, C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
28. Eckman, C. B. and Eckman, E. A. (2007) An update on the amyloid hypothesis. Neurol. Clin. 25, 669-682, vi.
29. Jarrett, J. T., Berger, E. P. and Lansbury, P. T., Jr. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
30. Vassar, R. and Citron, M. (2000) Abeta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron 27, 419-422.
31. Cai, X. D., Golde, T. E. and Younkin, S. G. (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259, 514-516.
32. Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T. and McGowan, E. (2007) Abeta40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627-633.
33. Murrell, J., Farlow, M., Ghetti, B. and Benson, M. D. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
34. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. and et al. (1991) Segregation of amissense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
35. Chartier-Harlin, M. C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J. and et al. (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353, 844-846.
36. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B. and Lannfelt, L. (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1, 345-347.
37. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D. J. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672-674.
38. Felsenstein, K. M., Hunihan, L. W. and Roberts, S. B. (1994) Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation. Nat. Genet. 6, 251-255.
39. Suzuki, N., Cheung, T. T., Cai, X. D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. E. and Younkin, S. G. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336-1340.
40. De Strooper, B. (2003) Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron 38, 9-12.
41. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T. and Selkoe, D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513-517.
42. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C. M., Kim, G., Seekins, S., Yager, D., Slunt, H. H., Wang, R., Seeger, M., Levey, A. I., Gandy, S. E., Copeland, N. G., Jenkins, N. A., Price, D. L., Younkin, S. G. and Sisodia, S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
43. Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St George Hyslop, P. and Selkoe, D. J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.
44. Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., Younkin, S. G. and Borchelt, D. R. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159-170.
45. Jankowsky, J. L., Younkin, L. H., Gonzales, V., Fadale, D. J., Slunt, H. H., Lester, H. A., Younkin, S. G. and Borchelt, D. R. (2007) Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J. Biol. Chem. 282, 22707-22720.
46. Duyckaerts, C., Potier, M. C. and Delatour, B. (2008) Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. 115, 5-38.
47. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F. and et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527.
48. Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D. and Hyman, B. T. (1997) Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053-7059.
49. Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L. and Sisodia, S. S. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945.
50. Janus, C., D'Amelio, S., Amitay, O., Chishti, M. A., Strome, R., Fraser, P., Carlson, G. A., Roder, J. C., St George-Hyslop, P. and Westaway, D. (2000) Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging 21, 541-549.
51. Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jaggi, F., Wolburg, H., Gengler, S., Haass, C., Ghetti, B., Czech, C., Holscher, C., Mathews, P. M. and Jucker, M. (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 7, 940-946.
52. Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J. and Frosch, M. P. (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 24, 516-524.
53. Lee, M. K., Borchelt, D. R., Kim, G., Thinakaran, G., Slunt, H. H., Ratovitski, T., Martin, L. J., Kittur, A., Gandy, S., Levey, A. I., Jenkins, N., Copeland, N., Price, D. L. and Sisodia, S. S. (1997) Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat. Med. 3, 756-760.
54. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y. and LaFerla, F. M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
55. Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A. and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053.
56. Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. and Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081.
57. Naslund, J., Haroutunian, V., Mohs, R., Davis, K. L., Davies, P., Greengard, P. and Buxbaum, J. D. (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 1571-1577.
58. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T. and Hyman, B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
59. Bussiere, T., Friend, P. D., Sadeghi, N., Wicinski, B., Lin, G. I., Bouras, C., Giannakopoulos, P., Robakis, N. K., Morrison, J. H., Perl, D. P. and Hof, P. R. (2002) Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 112, 75-91.
60. Klein, W. L., Krafft, G. A. and Finch, C. E. (2001) Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224.
61. Klein, W. L., Stine, W. B., Jr. and Teplow, D. B. (2004) Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging 25, 569-580.
62. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
63. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M. and Ashe, K. H. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
64. Kim, S. H., Tang, Y. P. and Sisodia, S. S. (2006) Abeta star: a light onto synaptic dysfunction? Nat Med 12, 760-1; discussion 761.
65. Lee, E. B., Leng, L. Z., Zhang, B., Kwong, L., Trojanowski, J. Q., Abel, T. and Lee, V. M. (2006) Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. J. Biol. Chem. 281, 4292-4299.
66. Jin, K., Peel, A. L., Mao, X. O., Xie, L., Cottrell, B. A., Henshall, D. C. and Greenberg, D. A. (2004) Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101, 343-347.
67. Yang, Y., Mufson, E. J. and Herrup, K. (2003) Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J. Neurosci. 23, 2557-2563.
68. Phillips, W., Michell, A. W. and Barker, R. A. (2006) Neurogenesis in diseases of the central nervous system. Stem Cells Dev. 15, 359-379.
69. Jin, K., Xie, L., Mao, X. O. and Greenberg, D. A. (2006) Alzheimer's disease drugs promote neurogenesis. Brain Res. 1085, 183-188.
70. Boekhoorn, K., Joels, M. and Lucassen, P. J. (2006) Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol. Dis. 24, 1-14.
71. Lovell, M. A., Geiger, H., Van Zant, G. E., Lynn, B. C. and Markesbery, W. R. (2006) Isolation of neural precursor cells from Alzheimer's disease and aged control post-mortem brain. Neurobiol. Aging 27, 909-917.
72. Ziabreva, I., Perry, E., Perry, R., Minger, S. L., Ekonomou, A., Przyborski, S. and Ballard, C. (2006) Altered neurogenesis in Alzheimer's disease. J. Psychosom. Res. 61, 311-316.
73. Bahn, S., Mimmack, M., Ryan, M., Caldwell, M. A., Jauniaux, E., Starkey, M., Svendsen, C. N. and Emson, P. (2002) Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 359, 310-315.
74. Jordan, J., Galindo, M. F. and Miller, R. J. (1997) Role of calpain- and interleukin-1 beta converting enzyme-like proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture. J. Neurochem. 68, 1612-1621.
75. Guo, Q., Sebastian, L., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M. and Mattson, M. P. (1999) Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J. Neurochem. 72, 1019-1029.
76. Mattson, M. P., Partin, J. and Begley, J. G. (1998) Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 807, 167-176.
77. Haughey, N. J., Nath, A., Chan, S. L., Borchard, A. C., Rao, M. S. and Mattson, M. P. (2002) Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J. Neurochem. 83, 1509-1524.
78. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R. E. (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
79. Heo, C., Chang, K. A., Choi, H. S., Kim, H. S., Kim, S., Liew, H., Kim, J. A., Yu, E., Ma, J. and Suh, Y. H. (2007) Effects of the monomeric, oligomeric, and fibrillar Abeta42 peptides on the proliferation and differentiation of adult neural stem cells from subventricular zone. J. Neurochem. 102, 493-500.
80. Lopez-Toledano, M. A. and Shelanski, M. L. (2004) Neurogenic effect of beta-amyloid peptide in the development of neural stem cells. J. Neurosci. 24, 5439-5444.
81. Kwak, Y. D., Brannen, C. L., Qu, T., Kim, H. M., Dong, X., Soba, P., Majumdar, A., Kaplan, A., Beyreuther, K. and Sugaya, K. (2006) Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev. 15, 381-389.
82. Cummings, B. J., Su, J. H. and Cotman, C. W. (1993) Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Exp. Neurol. 124, 315-325.
83. Stopa, E. G., Gonzalez, A. M., Chorsky, R., Corona, R. J., Alvarez, J., Bird, E. D. and Baird, A. (1990) Basic fibroblast growth factor in Alzheimer's disease. Biochem. Biophys. Res. Commun. 171, 690-696.
84. Durany, N., Michel, T., Kurt, J., Cruz-Sanchez, F. F., Cervas-Navarro, J. and Riederer, P. (2000) Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int. J. Dev. Neurosci. 18, 807-813.
85. Hock, C., Heese, K., Hulette, C., Rosenberg, C. and Otten, U. (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch. Neurol. 57, 846-851.
86. Chen, H., Tung, Y. C., Li, B., Iqbal, K. and Grundke-Iqbal, I. (2007) Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis. Neurobiol. Aging 28, 1148-1162.
87. Rai, K. S., Hattiangady, B. and Shetty, A. K. (2007) Enhanced production and dendritic growth of new dentate granule cells in the middle-aged hippocampus following intracerebroventricular FGF-2 infusions. Eur. J. Neurosci. 26, 1765-1779.
88. Uchida, Y., Nakano, S., Gomi, F. and Takahashi, H. (2007) Differential regulation of basic helix-loop-helix factors Mash1 and Olig2 by beta-amyloid accelerates both differentiation and death of cultured neural stem/progenitor cells. J. Biol. Chem. 282, 19700-19709.
89. Greeve, I., Hermans-Borgmeyer, I., Brellinger, C., Kasper, D., Gomez-Isla, T., Behl, C., Levkau, B. and Nitsch, R. M. (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 20, 7345-7352.
90. Benvenuti, S., Saccardi, R., Luciani, P., Urbani, S., Deledda, C., Cellai, I., Francini, F., Squecco, R., Rosati, F., Danza, G., Gelmini, S., Greeve, I., Rossi, M., Maggi, R., Serio, M. and Peri, A. (2006) Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1. Exp. Cell Res. 312, 2592-2604.
91. Donovan, M. H., Yazdani, U., Norris, R. D., Games, D., German, D. C. and Eisch, A. J. (2006) Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J. Comp. Neurol. 495, 70-83.
92. Cameron, H. A. and McKay, R. D. (2001) Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J. Comp. Neurol. 435, 406-417.
93. Jin, K., Galvan, V., Xie, L., Mao, X. O., Gorostiza, O. F., Bredesen, D. E. and Greenberg, D. A. (2004) Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw, Ind) mice. Proc Natl Acad Sci USA 101, 13363-13367.
94. Wen, P. H., Shao, X., Shao, Z., Hof, P. R., Wisniewski, T., Kelley, K., Friedrich, V. L., Jr., Ho, L., Pasinetti, G. M., Shioi, J., Robakis, N. K. and Elder, G. A. (2002) Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol. Dis. 10, 8-19.
95. Wen, P. H., Hof, P. R., Chen, X., Gluck, K., Austin, G., Younkin, S. G., Younkin, L. H., DeGasperi, R., Gama Sosa, M. A., Robakis, N. K., Haroutunian, V. and Elder, G. A. (2004) The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp. Neurol. 188, 224-237.
96. Wang, R., Dineley, K. T., Sweatt, J. D. and Zheng, H. (2004) Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 126, 305-312.
97. Verret, L., Jankowsky, J. L., Xu, G. M., Borchelt, D. R. and Rampon, C. (2007) Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J. Neurosci. 27, 6771-6780.
98. Zhang, C., McNeil, E., Dressler, L. and Siman, R. (2007) Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp. Neurol. 204, 77-87.
99. Maiorano, D., Lutzmann, M. and Mechali, M. (2006) MCM proteins and DNA replication. Curr. Opin. Cell. Biol. 18, 130-136.
100. Nakatomi, H., Kuriu, T., Okabe, S., Yamamoto, S., Hatano, O., Kawahara, N., Tamura, A., Kirino, T. and Nakafuku, M. (2002) Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110, 429-441.
101. Dong, H., Csernansky, C. A., Goico, B. and Csernansky, J. G. (2003) Hippocampal neurogenesis follows kainic acid-induced apoptosis in neonatal rats. J. Neurosci. 23, 1742-1749.
102. Liu, S., Wang, J., Zhu, D., Fu, Y., Lukowiak, K. and Lu, Y. M. (2003) Generation of functional inhibitory neurons in the adult rat hippocampus. J. Neurosci. 23, 732-736.
103. Zhao, C., Deng, W. and Gage, F. H. (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132, 645-660.
104. Tuszynski, M. H., U, H. S., Amaral, D. G. and Gage, F. H. (1990) Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 10, 3604-3614.
105. Fischer, W., Wictorin, K., Bjorklund, A., Williams, L. R., Varon, S. and Gage, F. H. (1987) Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329, 65-68.
106. Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., Tong, G., Potkin, S. G., Fallon, J., Hansen, L., Mufson, E. J., Kordower, J. H., Gall, C. and Conner, J. (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11, 551-555.
107. Kempermann, G., Gast, D. and Gage, F. H. (2002) Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment. Ann. Neurol. 52, 135-143.
108. Nithianantharajah, J. and Hannan, A. J. (2006) Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 7, 697-709.
109. Levi, O. and Michaelson, D. M. (2007) Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J. Neurochem. 100, 202-210.
110. Dhanushkodi, A. and Shetty, A. K. (2008) Is exposure to enriched environment beneficial for functional post-lesional recovery in temporal lobe epilepsy?Neurosci. Biobehav. Rev. 32, 657-674.
111. Hattiangady, B. and Shetty, A. K. (2007) Subcutaneous administration of BDNF dramatically enhances dentate neurogenesis in the injured aged hippocampus. SFN abstract 562.12